Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples